Allogeneic bone marrow transplantation : state of the art and future directions. SymposiumSCHAEFER, ULRICH W; BEELEN, DIETRICH W.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, issn 0951-3078, 88 p.Conference Proceedings

The lung as a critical organ in marrow transplantationQUABECK, K.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S19-S28, issn 0951-3078Conference Paper

Preparative regimens for patients with leukemias and severe aplastic anemia (overview): biological basis, experimental animal studies and clinical trials at the Fred Hutchinson cancer research centerSTORB, R.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S1-S3, issn 0951-3078Conference Paper

Functional ability and quality of life of patients after allogeneic bone marrow transplantationWINGARD, J. R.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S29-S33, issn 0951-3078Conference Paper

Late effects after allogeneic bone marrow transplantationDICKE, K. A.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S11-S13, issn 0951-3078Conference Paper

Biology of acute and chronic graft-versus-host reactions: predictive value of studies in experimental animalsVEN BEKKUM, D. W.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S51-S55, issn 0951-3078Conference Paper

Marrow transplantation using volunteer unrelated donors in a comparison of mismatched family donor transplants: a Seattle perspectiveBEATTY, P. G.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S39-S41, issn 0951-3078Conference Paper

New approaches to the prophylaxis and treatment of bacterial and fungal infections in allogeneic marrow transplant recipientsSCHULER, U; EHNINGER, G.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S61-S65, issn 0951-3078Conference Paper

Molecular techniques for typing unrelated marrow donors: potential impact of molecular typing disparity on donor selectionBAXTER-LOWE, L. A.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S42-S50, issn 0951-3078Conference Paper

Prophylaxis and treatment of acute graft-versus-host disease: current state, implications of new immunopharmacologic compounds and future strategies to prevent and treat acute GVHD in high-risk patientsDEEG, H. J.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S56-S60, issn 0951-3078Conference Paper

Selective reconstitution of CD8⁺ cytotoxoc T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clonesRIDDELL, S. R; WALTER, B. A; GILBERT, M. J et al.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S78-S84, issn 0951-3078Conference Paper

Role of marrow microenvironment in engraftment and maintenance of allogeneic hematopoietic stem cellsTOROK-STORB, B; HOLMBERG, L.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S71-S73, issn 0951-3078Conference Paper

Early detection and treatment of cytomegalovirus infections in marrow transplant patients: methodological aspects and implications for therapeutic interventionsBOECKH, M; MYERSON, D; BOWDEN, R. A et al.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S66-S70, issn 0951-3078Conference Paper

Hematopoietic growth factors after allogeneic marrow transplantation in animal studies and clinical trialsSCHUENING, F. G; NEMUNAITIS, J; APPELBAUM, F. R et al.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S74-S77, issn 0951-3078Conference Paper

Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantationBLUME, K. G; LONG, G. D; NEGRIN, R. S et al.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S9-S10, issn 0951-3078Conference Paper

Radiobiology of total body radiationVRIESENDORP, H. M; CHU, H; OCHRAN, T. G et al.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S4-S8, issn 0951-3078Conference Paper

Immunogenetic marrow donor search for 1012 patients: a retrospective analysis of strategies, outcome and costsOTTINGER, H; GROSSE-WILDE, M; SCHMITZ, A et al.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S34-S38, issn 0951-3078Conference Paper

Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategiesKLINGEMANN, H.-G; SHEPHERD, J. D; REECE, D. E et al.Bone marrow transplantation. Supplement (Basingstoke). 1994, Vol 14, Num 4, pp S14-S18, issn 0951-3078Conference Paper

Transfer of humoral and cellular hepatitis B immunity by allogeneic hematopoietic cell transplantationLINDEMANN, Monika; BARSEGIAN, Vahé; RUNDE, Volker et al.Transplantation. 2003, Vol 75, Num 6, pp 833-838, issn 0041-1337, 6 p.Article

Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction methodELMAAGACLI, Ahmet H; FREIST, Annette; HAHN, Meinhard et al.British journal of haematology. 2001, Vol 113, Num 4, pp 1072-1075, issn 0007-1048Article

Outcome of transplantation of highly purified peripheral blood CD34⁺ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemiaELMAAGACLI, Ahmet H; PECENY, Rudolf; STECKEL, Nina et al.Blood. 2003, Vol 101, Num 2, pp 446-453, issn 0006-4971, 8 p.Article

Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemiaELMAAGACLI, Ahmet H; BASOGLU, Semiha; PECENY, Rudolf et al.Blood. 2002, Vol 99, Num 4, pp 1130-1135, issn 0006-4971Article

Positive serum crossmatch as predictor for graft failure in HLA-mismatched allogeneic blood stem cell transplantationOTTINGER, Hellmut D; REBMANN, Vera; PFEIFFER, Kerstin A et al.Transplantation. 2002, Vol 73, Num 8, pp 1280-1285, issn 0041-1337Article

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCTVAN ESSER, Joost W. J; VAN DER HOLT, Bronno; OSTERHAUS, Albert D. M. E et al.Blood. 2001, Vol 98, Num 4, pp 972-978, issn 0006-4971Article